nodes	percent_of_prediction	percent_of_DWPC	metapath
Gefitinib—ALB—hepatitis B	0.41	1	CbGaD
Gefitinib—ABCG2—Lamivudine—hepatitis B	0.0648	0.735	CbGbCtD
Gefitinib—ABCB1—Lamivudine—hepatitis B	0.0234	0.265	CbGbCtD
Gefitinib—ORM1—saliva—hepatitis B	0.00944	0.11	CbGeAlD
Gefitinib—STK10—blood plasma—hepatitis B	0.00567	0.0658	CbGeAlD
Gefitinib—SBK1—blood—hepatitis B	0.00504	0.0585	CbGeAlD
Gefitinib—Tenderness—Telbivudine—hepatitis B	0.00483	0.0246	CcSEcCtD
Gefitinib—CHEK2—blood—hepatitis B	0.00439	0.051	CbGeAlD
Gefitinib—Hepatic failure—Entecavir—hepatitis B	0.00414	0.0211	CcSEcCtD
Gefitinib—Hepatic failure—Adefovir Dipivoxil—hepatitis B	0.00404	0.0206	CcSEcCtD
Gefitinib—Hypoxia—Lamivudine—hepatitis B	0.00374	0.019	CcSEcCtD
Gefitinib—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.0032	0.0163	CcSEcCtD
Gefitinib—Pancreatitis—Entecavir—hepatitis B	0.00315	0.016	CcSEcCtD
Gefitinib—Pancreatitis—Adefovir Dipivoxil—hepatitis B	0.00308	0.0156	CcSEcCtD
Gefitinib—Amblyopia—Lamivudine—hepatitis B	0.00307	0.0156	CcSEcCtD
Gefitinib—CYP2C19—blood plasma—hepatitis B	0.0029	0.0337	CbGeAlD
Gefitinib—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.00284	0.0144	CcSEcCtD
Gefitinib—Acne—Lamivudine—hepatitis B	0.00282	0.0143	CcSEcCtD
Gefitinib—CSNK1E—blood—hepatitis B	0.00278	0.0323	CbGeAlD
Gefitinib—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.00275	0.014	CcSEcCtD
Gefitinib—IRAK4—blood—hepatitis B	0.00274	0.0318	CbGeAlD
Gefitinib—Haematuria—Entecavir—hepatitis B	0.00273	0.0139	CcSEcCtD
Gefitinib—Hepatobiliary disease—Entecavir—hepatitis B	0.00271	0.0138	CcSEcCtD
Gefitinib—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.0027	0.0137	CcSEcCtD
Gefitinib—Haematuria—Adefovir Dipivoxil—hepatitis B	0.00267	0.0136	CcSEcCtD
Gefitinib—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.00265	0.0135	CcSEcCtD
Gefitinib—Hepatitis—Entecavir—hepatitis B	0.00257	0.0131	CcSEcCtD
Gefitinib—Drug interaction—Lamivudine—hepatitis B	0.00256	0.013	CcSEcCtD
Gefitinib—MKNK2—blood—hepatitis B	0.00255	0.0297	CbGeAlD
Gefitinib—IRAK1—blood—hepatitis B	0.00255	0.0297	CbGeAlD
Gefitinib—Oedema peripheral—Entecavir—hepatitis B	0.00254	0.0129	CcSEcCtD
Gefitinib—MKNK1—blood—hepatitis B	0.00252	0.0293	CbGeAlD
Gefitinib—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.00251	0.0128	CcSEcCtD
Gefitinib—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00248	0.0126	CcSEcCtD
Gefitinib—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00246	0.0125	CcSEcCtD
Gefitinib—CYP3A5—blood plasma—hepatitis B	0.00229	0.0265	CbGeAlD
Gefitinib—Alopecia—Entecavir—hepatitis B	0.00228	0.0116	CcSEcCtD
Gefitinib—EGFR—liver—hepatitis B	0.00226	0.0263	CbGeAlD
Gefitinib—CYP2C9—blood plasma—hepatitis B	0.00225	0.0261	CbGeAlD
Gefitinib—Malnutrition—Entecavir—hepatitis B	0.00224	0.0114	CcSEcCtD
Gefitinib—Hepatobiliary disease—Telbivudine—hepatitis B	0.00223	0.0113	CcSEcCtD
Gefitinib—Cisapride—CYP2A6—hepatitis B	0.00219	0.593	CrCbGaD
Gefitinib—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00219	0.0111	CcSEcCtD
Gefitinib—CSNK1E—liver—hepatitis B	0.00218	0.0253	CbGeAlD
Gefitinib—Mouth ulceration—Lamivudine—hepatitis B	0.00215	0.0109	CcSEcCtD
Gefitinib—IRAK4—liver—hepatitis B	0.00214	0.0249	CbGeAlD
Gefitinib—Hepatitis—Telbivudine—hepatitis B	0.00211	0.0108	CcSEcCtD
Gefitinib—ERBB3—liver—hepatitis B	0.0021	0.0244	CbGeAlD
Gefitinib—STK10—blood—hepatitis B	0.00208	0.0241	CbGeAlD
Gefitinib—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00202	0.0103	CcSEcCtD
Gefitinib—MKNK2—liver—hepatitis B	0.002	0.0232	CbGeAlD
Gefitinib—IRAK1—liver—hepatitis B	0.002	0.0232	CbGeAlD
Gefitinib—MKNK1—liver—hepatitis B	0.00197	0.0229	CbGeAlD
Gefitinib—Cough—Adefovir Dipivoxil—hepatitis B	0.00191	0.00971	CcSEcCtD
Gefitinib—Mediastinal disorder—Telbivudine—hepatitis B	0.00191	0.00969	CcSEcCtD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00189	0.00964	CcSEcCtD
Gefitinib—MAP2K5—blood—hepatitis B	0.00185	0.0215	CbGeAlD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00185	0.0094	CcSEcCtD
Gefitinib—Malnutrition—Telbivudine—hepatitis B	0.00184	0.00936	CcSEcCtD
Gefitinib—Infection—Entecavir—hepatitis B	0.00182	0.00924	CcSEcCtD
Gefitinib—Nervous system disorder—Entecavir—hepatitis B	0.00179	0.00912	CcSEcCtD
Gefitinib—Skin disorder—Entecavir—hepatitis B	0.00178	0.00904	CcSEcCtD
Gefitinib—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00175	0.0089	CcSEcCtD
Gefitinib—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00175	0.00889	CcSEcCtD
Gefitinib—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00173	0.00882	CcSEcCtD
Gefitinib—CYP3A4—blood plasma—hepatitis B	0.00172	0.0199	CbGeAlD
Gefitinib—Anorexia—Adefovir Dipivoxil—hepatitis B	0.0017	0.00865	CcSEcCtD
Gefitinib—CYP2D6—blood plasma—hepatitis B	0.00169	0.0196	CbGeAlD
Gefitinib—Malaise—Telbivudine—hepatitis B	0.00166	0.00844	CcSEcCtD
Gefitinib—STK10—liver—hepatitis B	0.00162	0.0189	CbGeAlD
Gefitinib—Cough—Telbivudine—hepatitis B	0.00161	0.00817	CcSEcCtD
Gefitinib—Dehydration—Lamivudine—hepatitis B	0.0016	0.00815	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Entecavir—hepatitis B	0.00158	0.00803	CcSEcCtD
Gefitinib—Fatigue—Entecavir—hepatitis B	0.00158	0.00802	CcSEcCtD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00156	0.00792	CcSEcCtD
Gefitinib—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.00155	0.00789	CcSEcCtD
Gefitinib—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00155	0.00789	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00154	0.00784	CcSEcCtD
Gefitinib—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.00152	0.00773	CcSEcCtD
Gefitinib—ORM1—blood—hepatitis B	0.00151	0.0175	CbGeAlD
Gefitinib—Gastrointestinal pain—Entecavir—hepatitis B	0.0015	0.00761	CcSEcCtD
Gefitinib—Nervous system disorder—Telbivudine—hepatitis B	0.00147	0.00749	CcSEcCtD
Gefitinib—Thrombocytopenia—Telbivudine—hepatitis B	0.00147	0.00748	CcSEcCtD
Gefitinib—Pancreatitis—Lamivudine—hepatitis B	0.00146	0.00743	CcSEcCtD
Gefitinib—Skin disorder—Telbivudine—hepatitis B	0.00146	0.00742	CcSEcCtD
Gefitinib—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00146	0.00742	CcSEcCtD
Gefitinib—MAP2K5—liver—hepatitis B	0.00145	0.0168	CbGeAlD
Gefitinib—Body temperature increased—Entecavir—hepatitis B	0.00145	0.00735	CcSEcCtD
Gefitinib—Abdominal pain—Entecavir—hepatitis B	0.00145	0.00735	CcSEcCtD
Gefitinib—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00141	0.00718	CcSEcCtD
Gefitinib—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00141	0.00718	CcSEcCtD
Gefitinib—Stevens-Johnson syndrome—Lamivudine—hepatitis B	0.00132	0.0067	CcSEcCtD
Gefitinib—Asthenia—Entecavir—hepatitis B	0.00131	0.00667	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Telbivudine—hepatitis B	0.0013	0.0066	CcSEcCtD
Gefitinib—Fatigue—Telbivudine—hepatitis B	0.0013	0.00659	CcSEcCtD
Gefitinib—Stomatitis—Lamivudine—hepatitis B	0.00129	0.00658	CcSEcCtD
Gefitinib—Pain—Telbivudine—hepatitis B	0.00128	0.00654	CcSEcCtD
Gefitinib—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00128	0.00651	CcSEcCtD
Gefitinib—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00126	0.00642	CcSEcCtD
Gefitinib—Hepatobiliary disease—Lamivudine—hepatitis B	0.00126	0.00639	CcSEcCtD
Gefitinib—Epistaxis—Lamivudine—hepatitis B	0.00125	0.00637	CcSEcCtD
Gefitinib—Diarrhoea—Entecavir—hepatitis B	0.00125	0.00637	CcSEcCtD
Gefitinib—Gastrointestinal pain—Telbivudine—hepatitis B	0.00123	0.00625	CcSEcCtD
Gefitinib—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00122	0.00621	CcSEcCtD
Gefitinib—ABCB1—blood plasma—hepatitis B	0.00121	0.0141	CbGeAlD
Gefitinib—Hepatitis—Lamivudine—hepatitis B	0.00119	0.00606	CcSEcCtD
Gefitinib—Body temperature increased—Telbivudine—hepatitis B	0.00119	0.00604	CcSEcCtD
Gefitinib—Abdominal pain—Telbivudine—hepatitis B	0.00119	0.00604	CcSEcCtD
Gefitinib—ORM1—liver—hepatitis B	0.00118	0.0137	CbGeAlD
Gefitinib—Vomiting—Entecavir—hepatitis B	0.00116	0.00592	CcSEcCtD
Gefitinib—Rash—Entecavir—hepatitis B	0.00115	0.00587	CcSEcCtD
Gefitinib—Dermatitis—Entecavir—hepatitis B	0.00115	0.00586	CcSEcCtD
Gefitinib—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00113	0.00577	CcSEcCtD
Gefitinib—Erythema multiforme—Lamivudine—hepatitis B	0.00113	0.00573	CcSEcCtD
Gefitinib—Rash—Adefovir Dipivoxil—hepatitis B	0.00113	0.00572	CcSEcCtD
Gefitinib—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00112	0.00572	CcSEcCtD
Gefitinib—Nausea—Entecavir—hepatitis B	0.00109	0.00553	CcSEcCtD
Gefitinib—Asthenia—Telbivudine—hepatitis B	0.00108	0.00548	CcSEcCtD
Gefitinib—Mediastinal disorder—Lamivudine—hepatitis B	0.00107	0.00546	CcSEcCtD
Gefitinib—CYP2C19—blood—hepatitis B	0.00106	0.0123	CbGeAlD
Gefitinib—Pruritus—Telbivudine—hepatitis B	0.00106	0.00541	CcSEcCtD
Gefitinib—Nausea—Adefovir Dipivoxil—hepatitis B	0.00106	0.00539	CcSEcCtD
Gefitinib—Alopecia—Lamivudine—hepatitis B	0.00105	0.00536	CcSEcCtD
Gefitinib—Malnutrition—Lamivudine—hepatitis B	0.00104	0.00528	CcSEcCtD
Gefitinib—ALB—liver—hepatitis B	0.00103	0.012	CbGeAlD
Gefitinib—Diarrhoea—Telbivudine—hepatitis B	0.00103	0.00523	CcSEcCtD
Gefitinib—Anaemia—Lamivudine—hepatitis B	0.000959	0.00488	CcSEcCtD
Gefitinib—Vomiting—Telbivudine—hepatitis B	0.000955	0.00486	CcSEcCtD
Gefitinib—Angioedema—Lamivudine—hepatitis B	0.000948	0.00482	CcSEcCtD
Gefitinib—Rash—Telbivudine—hepatitis B	0.000947	0.00482	CcSEcCtD
Gefitinib—Dermatitis—Telbivudine—hepatitis B	0.000947	0.00481	CcSEcCtD
Gefitinib—Malaise—Lamivudine—hepatitis B	0.000936	0.00476	CcSEcCtD
Gefitinib—Erlotinib—ALB—hepatitis B	0.000906	0.246	CrCbGaD
Gefitinib—Cough—Lamivudine—hepatitis B	0.000905	0.00461	CcSEcCtD
Gefitinib—ABCG2—blood—hepatitis B	0.000902	0.0105	CbGeAlD
Gefitinib—Nausea—Telbivudine—hepatitis B	0.000893	0.00454	CcSEcCtD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.000877	0.00446	CcSEcCtD
Gefitinib—Dry mouth—Lamivudine—hepatitis B	0.000864	0.00439	CcSEcCtD
Gefitinib—CYP1A1—blood—hepatitis B	0.000857	0.00994	CbGeAlD
Gefitinib—Infection—Lamivudine—hepatitis B	0.000841	0.00428	CcSEcCtD
Gefitinib—CYP3A5—blood—hepatitis B	0.000838	0.00972	CbGeAlD
Gefitinib—Shock—Lamivudine—hepatitis B	0.000833	0.00424	CcSEcCtD
Gefitinib—CYP2C19—liver—hepatitis B	0.000831	0.00965	CbGeAlD
Gefitinib—Nervous system disorder—Lamivudine—hepatitis B	0.00083	0.00422	CcSEcCtD
Gefitinib—Thrombocytopenia—Lamivudine—hepatitis B	0.000829	0.00422	CcSEcCtD
Gefitinib—CYP2C9—blood—hepatitis B	0.000824	0.00957	CbGeAlD
Gefitinib—Skin disorder—Lamivudine—hepatitis B	0.000823	0.00418	CcSEcCtD
Gefitinib—Anorexia—Lamivudine—hepatitis B	0.000807	0.00411	CcSEcCtD
Gefitinib—Hypotension—Lamivudine—hepatitis B	0.000791	0.00402	CcSEcCtD
Gefitinib—Dyspnoea—Lamivudine—hepatitis B	0.000755	0.00384	CcSEcCtD
Gefitinib—Decreased appetite—Lamivudine—hepatitis B	0.000736	0.00374	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Lamivudine—hepatitis B	0.000731	0.00372	CcSEcCtD
Gefitinib—Fatigue—Lamivudine—hepatitis B	0.00073	0.00371	CcSEcCtD
Gefitinib—Constipation—Lamivudine—hepatitis B	0.000724	0.00368	CcSEcCtD
Gefitinib—Pain—Lamivudine—hepatitis B	0.000724	0.00368	CcSEcCtD
Gefitinib—ABCG2—liver—hepatitis B	0.000706	0.00819	CbGeAlD
Gefitinib—Gastrointestinal pain—Lamivudine—hepatitis B	0.000692	0.00352	CcSEcCtD
Gefitinib—Urticaria—Lamivudine—hepatitis B	0.000673	0.00342	CcSEcCtD
Gefitinib—CYP1A1—liver—hepatitis B	0.00067	0.00778	CbGeAlD
Gefitinib—Body temperature increased—Lamivudine—hepatitis B	0.000669	0.0034	CcSEcCtD
Gefitinib—Abdominal pain—Lamivudine—hepatitis B	0.000669	0.0034	CcSEcCtD
Gefitinib—CYP3A5—liver—hepatitis B	0.000655	0.0076	CbGeAlD
Gefitinib—CYP2C9—liver—hepatitis B	0.000645	0.00748	CbGeAlD
Gefitinib—CYP3A4—blood—hepatitis B	0.000629	0.0073	CbGeAlD
Gefitinib—Hypersensitivity—Lamivudine—hepatitis B	0.000624	0.00317	CcSEcCtD
Gefitinib—CYP2D6—blood—hepatitis B	0.000618	0.00718	CbGeAlD
Gefitinib—Asthenia—Lamivudine—hepatitis B	0.000608	0.00309	CcSEcCtD
Gefitinib—Pruritus—Lamivudine—hepatitis B	0.000599	0.00305	CcSEcCtD
Gefitinib—Vandetanib—ALB—hepatitis B	0.000597	0.162	CrCbGaD
Gefitinib—Diarrhoea—Lamivudine—hepatitis B	0.000579	0.00295	CcSEcCtD
Gefitinib—Vomiting—Lamivudine—hepatitis B	0.000538	0.00274	CcSEcCtD
Gefitinib—Rash—Lamivudine—hepatitis B	0.000534	0.00272	CcSEcCtD
Gefitinib—Dermatitis—Lamivudine—hepatitis B	0.000533	0.00271	CcSEcCtD
Gefitinib—Nausea—Lamivudine—hepatitis B	0.000503	0.00256	CcSEcCtD
Gefitinib—CYP3A4—liver—hepatitis B	0.000492	0.00571	CbGeAlD
Gefitinib—CYP2D6—liver—hepatitis B	0.000484	0.00561	CbGeAlD
Gefitinib—ABCB1—blood—hepatitis B	0.000445	0.00516	CbGeAlD
Gefitinib—ABCB1—liver—hepatitis B	0.000348	0.00404	CbGeAlD
Gefitinib—EGFR—Immune System—IFNB1—hepatitis B	4.12e-05	0.000191	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—IFNA2—hepatitis B	4.11e-05	0.000191	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—CD4—hepatitis B	4.07e-05	0.000189	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—CXCL10—hepatitis B	4.06e-05	0.000189	CbGpPWpGaD
Gefitinib—ERBB3—Disease—NOS2—hepatitis B	4.04e-05	0.000188	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—CDKN1A—hepatitis B	4.02e-05	0.000187	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IFNA1—hepatitis B	4.02e-05	0.000187	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—PTEN—hepatitis B	4.02e-05	0.000187	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—NFKB1—hepatitis B	4e-05	0.000186	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—GGT2—hepatitis B	3.98e-05	0.000185	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—CD4—hepatitis B	3.93e-05	0.000183	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	3.85e-05	0.000179	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—TLR4—hepatitis B	3.83e-05	0.000178	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—HLA-DRB1—hepatitis B	3.83e-05	0.000178	CbGpPWpGaD
Gefitinib—EGFR—NGF signalling via TRKA from the plasma membrane—IL6—hepatitis B	3.82e-05	0.000178	CbGpPWpGaD
Gefitinib—ALB—Metabolism—AKR1B1—hepatitis B	3.79e-05	0.000176	CbGpPWpGaD
Gefitinib—IRAK4—Innate Immune System—IL6—hepatitis B	3.78e-05	0.000176	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—F2—hepatitis B	3.76e-05	0.000175	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—IL2—hepatitis B	3.74e-05	0.000174	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CD14—hepatitis B	3.74e-05	0.000174	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IFNA2—hepatitis B	3.74e-05	0.000174	CbGpPWpGaD
Gefitinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hepatitis B	3.7e-05	0.000172	CbGpPWpGaD
Gefitinib—ALB—Metabolism—GGT2—hepatitis B	3.63e-05	0.000169	CbGpPWpGaD
Gefitinib—MKNK1—Disease—TGFB1—hepatitis B	3.63e-05	0.000169	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—CTNNB1—hepatitis B	3.62e-05	0.000168	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—CXCL10—hepatitis B	3.59e-05	0.000167	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—CYP2A6—hepatitis B	3.56e-05	0.000166	CbGpPWpGaD
Gefitinib—EGFR—Disease—GOT1—hepatitis B	3.56e-05	0.000165	CbGpPWpGaD
Gefitinib—ALB—Platelet activation, signaling and aggregation—IL2—hepatitis B	3.54e-05	0.000165	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—CDKN1A—hepatitis B	3.53e-05	0.000164	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—PTEN—hepatitis B	3.52e-05	0.000164	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—NFKB1—hepatitis B	3.51e-05	0.000163	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—CTNNB1—hepatitis B	3.49e-05	0.000162	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—CCR5—hepatitis B	3.47e-05	0.000161	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	3.46e-05	0.000161	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—CDKN1A—hepatitis B	3.41e-05	0.000159	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—PTEN—hepatitis B	3.4e-05	0.000158	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—AKR1B1—hepatitis B	3.4e-05	0.000158	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	3.37e-05	0.000157	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—IFNG—hepatitis B	3.36e-05	0.000156	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—CCR5—hepatitis B	3.34e-05	0.000155	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—AKR1B1—hepatitis B	3.32e-05	0.000154	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	3.29e-05	0.000153	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	3.28e-05	0.000153	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	3.27e-05	0.000152	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—GGT2—hepatitis B	3.26e-05	0.000151	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—IL2—hepatitis B	3.26e-05	0.000151	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—CD4—hepatitis B	3.24e-05	0.000151	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—GOT2—hepatitis B	3.22e-05	0.00015	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IL18—hepatitis B	3.19e-05	0.000148	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CD40LG—hepatitis B	3.18e-05	0.000148	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—GGT2—hepatitis B	3.18e-05	0.000148	CbGpPWpGaD
Gefitinib—ABCG2—Transmembrane transport of small molecules—ALB—hepatitis B	3.16e-05	0.000147	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	3.15e-05	0.000147	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—CCR5—hepatitis B	3.15e-05	0.000146	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CD8A—hepatitis B	3.15e-05	0.000146	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—CTNNB1—hepatitis B	3.14e-05	0.000146	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—AKR1B1—hepatitis B	3.13e-05	0.000145	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—CTNNB1—hepatitis B	3.12e-05	0.000145	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—CD4—hepatitis B	3.1e-05	0.000144	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—AKR1B1—hepatitis B	3.1e-05	0.000144	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—CDKN1A—hepatitis B	3.07e-05	0.000143	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—PTEN—hepatitis B	3.07e-05	0.000142	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—NFKB1—hepatitis B	3.05e-05	0.000142	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—NFKB1—hepatitis B	3.03e-05	0.000141	CbGpPWpGaD
Gefitinib—ERBB3—Innate Immune System—IL6—hepatitis B	3.01e-05	0.00014	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—GGT2—hepatitis B	3e-05	0.000139	CbGpPWpGaD
Gefitinib—ERBB3—Disease—CD4—hepatitis B	3e-05	0.000139	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—IL2—hepatitis B	2.99e-05	0.000139	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—CD4—hepatitis B	2.98e-05	0.000138	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—F2—hepatitis B	2.97e-05	0.000138	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—GGT2—hepatitis B	2.97e-05	0.000138	CbGpPWpGaD
Gefitinib—EGFR—Signaling by NGF—IL6—hepatitis B	2.94e-05	0.000137	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—CTNNB1—hepatitis B	2.88e-05	0.000134	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—F2—hepatitis B	2.87e-05	0.000133	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—TGFB1—hepatitis B	2.82e-05	0.000131	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—CDKN1A—hepatitis B	2.82e-05	0.000131	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—PTEN—hepatitis B	2.81e-05	0.000131	CbGpPWpGaD
Gefitinib—EGFR—Immune System—HLA-A—hepatitis B	2.8e-05	0.00013	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—IFNG—hepatitis B	2.8e-05	0.00013	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—NFKB1—hepatitis B	2.8e-05	0.00013	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—GGT1—hepatitis B	2.78e-05	0.000129	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—GOT1—hepatitis B	2.78e-05	0.000129	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—CCR5—hepatitis B	2.78e-05	0.000129	CbGpPWpGaD
Gefitinib—ALB—Platelet activation, signaling and aggregation—TGFB1—hepatitis B	2.76e-05	0.000128	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—CTNNB1—hepatitis B	2.75e-05	0.000128	CbGpPWpGaD
Gefitinib—MKNK1—Disease—IL6—hepatitis B	2.73e-05	0.000127	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	2.72e-05	0.000126	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—F2—hepatitis B	2.71e-05	0.000126	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—CD4—hepatitis B	2.7e-05	0.000126	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—F2—hepatitis B	2.7e-05	0.000126	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—CDKN1A—hepatitis B	2.69e-05	0.000125	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—PTEN—hepatitis B	2.69e-05	0.000125	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—NOS2—hepatitis B	2.68e-05	0.000125	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—NFKB1—hepatitis B	2.67e-05	0.000124	CbGpPWpGaD
Gefitinib—EGFR—Axon guidance—IL6—hepatitis B	2.66e-05	0.000124	CbGpPWpGaD
Gefitinib—ERBB3—Disease—CTNNB1—hepatitis B	2.66e-05	0.000124	CbGpPWpGaD
Gefitinib—EGFR—Disease—CCR5—hepatitis B	2.66e-05	0.000123	CbGpPWpGaD
Gefitinib—ERBB3—Disease—CDKN1A—hepatitis B	2.6e-05	0.000121	CbGpPWpGaD
Gefitinib—ERBB3—Disease—PTEN—hepatitis B	2.59e-05	0.000121	CbGpPWpGaD
Gefitinib—EGFR—Disease—HLA-A—hepatitis B	2.59e-05	0.00012	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—CDKN1A—hepatitis B	2.58e-05	0.00012	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—PTEN—hepatitis B	2.58e-05	0.00012	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—NFKB1—hepatitis B	2.57e-05	0.000119	CbGpPWpGaD
Gefitinib—EGFR—Immune System—TLR4—hepatitis B	2.56e-05	0.000119	CbGpPWpGaD
Gefitinib—EGFR—Immune System—HLA-DRB1—hepatitis B	2.56e-05	0.000119	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—CYP2A6—hepatitis B	2.55e-05	0.000119	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—TGFB1—hepatitis B	2.54e-05	0.000118	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	2.54e-05	0.000118	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—IL2—hepatitis B	2.53e-05	0.000118	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—TGFB1—hepatitis B	2.52e-05	0.000117	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—IL6—hepatitis B	2.51e-05	0.000117	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—IL2—hepatitis B	2.49e-05	0.000116	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—CTNNB1—hepatitis B	2.45e-05	0.000114	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—CYP2A6—hepatitis B	2.41e-05	0.000112	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—CTNNB1—hepatitis B	2.4e-05	0.000112	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CXCL10—hepatitis B	2.4e-05	0.000111	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—CDKN1A—hepatitis B	2.39e-05	0.000111	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—F2—hepatitis B	2.39e-05	0.000111	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—PTEN—hepatitis B	2.38e-05	0.000111	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—NFKB1—hepatitis B	2.37e-05	0.00011	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—TNF—hepatitis B	2.35e-05	0.000109	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—CDKN1A—hepatitis B	2.34e-05	0.000109	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—PTEN—hepatitis B	2.34e-05	0.000109	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—NFKB1—hepatitis B	2.33e-05	0.000108	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—GOT2—hepatitis B	2.31e-05	0.000107	CbGpPWpGaD
Gefitinib—EGFR—Disease—NOS2—hepatitis B	2.25e-05	0.000105	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—ALB—hepatitis B	2.25e-05	0.000105	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	2.24e-05	0.000104	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—IL6—hepatitis B	2.2e-05	0.000102	CbGpPWpGaD
Gefitinib—ALB—Metabolism—CYP2A6—hepatitis B	2.2e-05	0.000102	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—GOT2—hepatitis B	2.18e-05	0.000101	CbGpPWpGaD
Gefitinib—ERBB3—Disease—TGFB1—hepatitis B	2.15e-05	9.99e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—IL6—hepatitis B	2.13e-05	9.88e-05	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—TP53—hepatitis B	2.09e-05	9.72e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—AKR1B1—hepatitis B	2.04e-05	9.5e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—IL2—hepatitis B	2e-05	9.31e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—GOT1—hepatitis B	1.99e-05	9.26e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—GGT1—hepatitis B	1.99e-05	9.26e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—GOT2—hepatitis B	1.99e-05	9.24e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—TGFB1—hepatitis B	1.98e-05	9.18e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—CYP2A6—hepatitis B	1.97e-05	9.17e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—GGT2—hepatitis B	1.96e-05	9.11e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—CTNNB1—hepatitis B	1.93e-05	8.99e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—IL2—hepatitis B	1.93e-05	8.97e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—CYP2A6—hepatitis B	1.93e-05	8.95e-05	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—IL6—hepatitis B	1.91e-05	8.9e-05	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—IL6—hepatitis B	1.9e-05	8.83e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—CDKN1A—hepatitis B	1.89e-05	8.78e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—PTEN—hepatitis B	1.88e-05	8.76e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—GGT1—hepatitis B	1.88e-05	8.75e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—GOT1—hepatitis B	1.88e-05	8.75e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—NFKB1—hepatitis B	1.88e-05	8.72e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IFNG—hepatitis B	1.87e-05	8.69e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—CTNNB1—hepatitis B	1.86e-05	8.66e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CCR5—hepatitis B	1.86e-05	8.64e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hepatitis B	1.84e-05	8.55e-05	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—IL2—hepatitis B	1.83e-05	8.49e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—CDKN1A—hepatitis B	1.82e-05	8.46e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—IL2—hepatitis B	1.82e-05	8.46e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—PTEN—hepatitis B	1.82e-05	8.44e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—CYP2A6—hepatitis B	1.82e-05	8.44e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—NFKB1—hepatitis B	1.81e-05	8.4e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CD4—hepatitis B	1.81e-05	8.4e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—CYP2A6—hepatitis B	1.8e-05	8.36e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—GOT2—hepatitis B	1.79e-05	8.3e-05	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—IL6—hepatitis B	1.75e-05	8.16e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—GOT2—hepatitis B	1.74e-05	8.1e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—GGT1—hepatitis B	1.72e-05	7.98e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—GOT1—hepatitis B	1.72e-05	7.98e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	1.72e-05	7.98e-05	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—ALB—hepatitis B	1.71e-05	7.94e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hepatitis B	1.68e-05	7.8e-05	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—IL6—hepatitis B	1.68e-05	7.8e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—CD4—hepatitis B	1.67e-05	7.75e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IL2—hepatitis B	1.66e-05	7.73e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—GOT2—hepatitis B	1.64e-05	7.63e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—GOT2—hepatitis B	1.63e-05	7.56e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—TP53—hepatitis B	1.63e-05	7.56e-05	CbGpPWpGaD
Gefitinib—ERBB3—Disease—IL6—hepatitis B	1.62e-05	7.53e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—IL2—hepatitis B	1.61e-05	7.47e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CTNNB1—hepatitis B	1.6e-05	7.46e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—F2—hepatitis B	1.6e-05	7.42e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CDKN1A—hepatitis B	1.57e-05	7.29e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	1.56e-05	7.27e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—PTEN—hepatitis B	1.56e-05	7.27e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—TGFB1—hepatitis B	1.56e-05	7.26e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—NFKB1—hepatitis B	1.56e-05	7.23e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—CTNNB1—hepatitis B	1.55e-05	7.21e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—GOT1—hepatitis B	1.54e-05	7.16e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—GGT1—hepatitis B	1.54e-05	7.16e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—CDKN1A—hepatitis B	1.52e-05	7.04e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—PTEN—hepatitis B	1.51e-05	7.03e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—TGFB1—hepatitis B	1.51e-05	7e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—NFKB1—hepatitis B	1.5e-05	6.99e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—GGT1—hepatitis B	1.5e-05	6.99e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—GOT1—hepatitis B	1.5e-05	6.99e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—IL6—hepatitis B	1.49e-05	6.92e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—CTNNB1—hepatitis B	1.48e-05	6.89e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—ALB—hepatitis B	1.48e-05	6.88e-05	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—IL6—hepatitis B	1.46e-05	6.79e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—CDKN1A—hepatitis B	1.45e-05	6.73e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—PTEN—hepatitis B	1.44e-05	6.71e-05	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—TGFB1—hepatitis B	1.42e-05	6.62e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—GOT1—hepatitis B	1.42e-05	6.59e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—GGT1—hepatitis B	1.42e-05	6.59e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—GOT1—hepatitis B	1.4e-05	6.53e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—GGT1—hepatitis B	1.4e-05	6.53e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	1.4e-05	6.53e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—TP53—hepatitis B	1.29e-05	5.98e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	1.28e-05	5.95e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—TGFB1—hepatitis B	1.25e-05	5.83e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—TP53—hepatitis B	1.24e-05	5.76e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—TGFB1—hepatitis B	1.2e-05	5.56e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—CYP2A6—hepatitis B	1.19e-05	5.52e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—IL6—hepatitis B	1.18e-05	5.47e-05	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—TP53—hepatitis B	1.17e-05	5.45e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—IL6—hepatitis B	1.13e-05	5.27e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—PTEN—hepatitis B	1.13e-05	5.25e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—IL2—hepatitis B	1.07e-05	4.99e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—GOT2—hepatitis B	1.07e-05	4.99e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—IL6—hepatitis B	1.07e-05	4.97e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—ALB—hepatitis B	1.06e-05	4.93e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CTNNB1—hepatitis B	1.04e-05	4.82e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—TP53—hepatitis B	1.03e-05	4.8e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CDKN1A—hepatitis B	1.01e-05	4.71e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—PTEN—hepatitis B	1.01e-05	4.7e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—NFKB1—hepatitis B	1.01e-05	4.68e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—ALB—hepatitis B	1e-05	4.66e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IL6—hepatitis B	9.77e-06	4.54e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—IL6—hepatitis B	9.45e-06	4.39e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—GGT1—hepatitis B	9.27e-06	4.31e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—GOT1—hepatitis B	9.27e-06	4.31e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—IL6—hepatitis B	9.02e-06	4.19e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—TGFB1—hepatitis B	8.38e-06	3.9e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—ALB—hepatitis B	8.2e-06	3.81e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—PTEN—hepatitis B	8.09e-06	3.76e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—ALB—hepatitis B	8e-06	3.72e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—PTEN—hepatitis B	7.64e-06	3.55e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—ALB—hepatitis B	7.54e-06	3.5e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—ALB—hepatitis B	7.47e-06	3.47e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—PTEN—hepatitis B	6.97e-06	3.24e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—TP53—hepatitis B	6.9e-06	3.21e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—IL6—hepatitis B	6.32e-06	2.94e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—PTEN—hepatitis B	6.25e-06	2.91e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—PTEN—hepatitis B	6.1e-06	2.84e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—PTEN—hepatitis B	5.75e-06	2.67e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—PTEN—hepatitis B	5.7e-06	2.65e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—ALB—hepatitis B	4.93e-06	2.29e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PTEN—hepatitis B	3.76e-06	1.75e-05	CbGpPWpGaD
